A Study of BMS-986466 With Adagrasib With or Without Cetuximab in Participants With Kirsten Rat Sarcoma Virus Glycine 12 to Cysteine (KRAS G12C)-Mutant Solid Tumors
Clinical trial NCT06024174 · TERMINATED
Trial details
- NCT number
- NCT06024174
- Sponsor
- Bristol-Myers Squibb
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-09
- Primary completion
- 2024-05-13
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.